Article requires registration
Continuous Production in the Pharmaceutical Industry Why Will it No Longer be Possible to Work without Continuous Production?
Continuous production has arrived in the pharmaceutical manufacturing sector and it’s not going away anytime soon. Spurred on by the ever-increasing number of innovative and at the same time very expensive active ingredients, the pharmaceutical industry is relying on technology to reach the market faster and to ensure less wastage of expensive active ingredient used for clinical samples, scale up and release procedures. How are new drugs changing the rules of the game in production?
Continuous production in pharmaceutical manufacturing – long considered a niche technology – is slowly but surely taking over the entire pharmaceutical industry. Since the FDA approved the Vertex preparation Orkambi in 2015 as the first drug produced with continuous direct compression, there is hardly a major international pharmaceutical company that is not involved in continuous production, says Harald Stahl, Head of Innovation & Strategy, at Gea Pharma & Healthcare.